SIGA Technologies, Inc. (SIGA)
NGM · Healthcare · Drug Manufacturers - Specialty & Generic
$3.34
+0.00%
Closing price as of 2026-07-29 · Source: TEK2day Finance
Key Metrics
Market Cap
$239.6M
Shares Outstanding
71.7M
P/S (TTM)
2.6x
Exchange
NGM
Currency
USD
About SIGA Technologies, Inc.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 81.1M | 2.6M | 3.8M | 6.2M |
| Gross Profit | 55.6M | 1.6M | 804K | 3.3M |
| Operating Income | 45.7M | -10.2M | -9.5M | -5.3M |
| Net Income | 35.5M | -6.4M | -5.4M | -3.5M |
| Diluted EPS | $0.49 | $-0.09 | $nan | $-0.05 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 110.8M | 139.9M | 138.7M | 94.6M |
| Gross Profit | 100.3M | 122.1M | 107.4M | 64.9M |
| Operating Income | 42.7M | 83.6M | 70.0M | 23.7M |
| Net Income | 33.9M | 68.1M | 59.2M | 23.3M |
| Diluted EPS | $0.46 | $0.95 | $0.82 | $0.32 |